COMPANY
GMP COMPLIANCE
GMP COMPLIANCE
TransTissue rapidly transfers laboratory processes to standardized and controlled procedures to produce tissue engineering and advanced therapy medicinal products and medical devices in compliance with GMP guidelines.
Two medicinal products, BioSeed®-C and BioSeed®-Oral Bone, as well as the medical device chondrotissue® developed by TransTissue and authorized for clinical use, are produced and distributed by BioTissue.
BioSeed®-C is an autologous 3D chondrocyte graft used to treat articular cartilage defects. BioSeed®-Oral Bone is a 3D jawbone graft. Chondrotissue® is a CE-marked cell-free matrix for treatment of cartilage in microfracture.
The products are manufactured in GMP laboratories in compliance with European legislation and subject to the stringent requirements of component authorities.
Two medicinal products, BioSeed®-C and BioSeed®-Oral Bone, as well as the medical device chondrotissue® developed by TransTissue and authorized for clinical use, are produced and distributed by BioTissue.
BioSeed®-C is an autologous 3D chondrocyte graft used to treat articular cartilage defects. BioSeed®-Oral Bone is a 3D jawbone graft. Chondrotissue® is a CE-marked cell-free matrix for treatment of cartilage in microfracture.
The products are manufactured in GMP laboratories in compliance with European legislation and subject to the stringent requirements of component authorities.